Cipla share price slumped over 7% on Thursday's trade wiping out the gains of the previous two weeks following the release of the warning letter, the US Food and Drug Administration (US FDA) sent to the company's Pithampur unit on Saturday, November 18. Cipla share price today opened at intraday high level of ₹1,272.95 apiece on BSE.
Cipla emerged as the top laggard in the Nifty 50 today so far. According to technical analysts, the Cipla shares have slipped after failing to sustain above the August month swing high around ₹1,280, but the fall is majorly because of news.
Read more on livemint.com